Filing Flows

Filing Flows › Comparisons › ATRC vs AORT

AtriCure vs Artivion: ATRC and AORT compared

AtriCure is the larger company: $154M of revenue in its latest quarter (Q3 2026) against $124M for Artivion (Q3 2026). AtriCure is growing faster (+15% against +9% a year earlier). AtriCure is more profitable, with an operating margin of 2.8% against 2.4%.

AtriCure vs Artivion, latest quarterAtriCure vs Artivion, latest quarterAtriCure (ATRC)Artivion (AORT)Revenue$154M$124MRevenue growth, Y/Y+15%+9%Operating margin2.8%2.4%Net margin2.6%-6.4%

Where the money goes: ATRC and AORT

AtriCure (ATRC) · Q3 2026

AtriCure, Q3 2026: revenue $154M (+15% year over year), operating margin 2.8%, net earnings $4.1M, operating cash flow $30.3M. The chart follows the revenue to costs, profit and cash.

Artivion (AORT) · Q3 2026

Artivion, Q3 2026: revenue $124M (+9% year over year), operating margin 2.4%, net loss $7.9M, operating cash flow −$4.6M. The chart follows the revenue to costs, profit and cash.

Artivion revenue by segment, Q3 2026Artivion revenue by segment, Q3 2026Products$98.2MPreservation services$25.6M
AtriCure (ATRC)Artivion (AORT)
Latest quarterQ3 2026Q3 2026
Revenue$154M$124M
Revenue growth, Y/Y+15%+9%
Gross margin77.3%—
Operating margin2.8%2.4%
Net earnings$4.1M−$7.9M
Net margin2.6%-6.4%
Operating cash flow$30.3M−$4.6M
Free cash flow$23.9M—

Where the revenue comes from

Artivion

Questions

Which is bigger, AtriCure or Artivion?

AtriCure is the larger company: $154M of revenue in its latest quarter (Q3 2026) against $124M for Artivion (Q3 2026).

Is AtriCure or Artivion growing faster?

AtriCure is growing faster (+15% against +9% a year earlier).

Which is more profitable, AtriCure or Artivion?

AtriCure is more profitable, with an operating margin of 2.8% against 2.4%.

More: AtriCure earnings · how AtriCure makes money · Artivion earnings · how Artivion makes money

From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 4, 2026; 10-Q filed Nov 6, 2026). Fiscal quarters can end on different dates. Not investment advice.